NCT03107091View on ClinicalTrials.gov

Continuous Infusion Terlipressin for Patients With Cirrhosis and Refractory Ascites

PHASE2CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

July 15, 2017

Primary Completion Date

April 1, 2019

Study Completion Date

April 25, 2019

Conditions
CirrhosisAscites Hepatic
Interventions
DRUG

Terlipressin acetate continuous infusion

Low-dose continuous infusion of Terlipressin administered via ambulatory pump over 28 days

Trial Locations (1)

23239

Hunter Holmes McGuire VA Medical Center, Richmond

Sponsors

Lead Sponsor

BioVie Inc.
All Listed Sponsors
lead

BioVie Inc.

INDUSTRY